Cerity Partners LLC Sangamo Therapeutics, Inc Transaction History
Cerity Partners LLC
- $60.5 Billion
- Q3 2025
A detailed history of Cerity Partners LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Cerity Partners LLC holds 179,668 shares of SGMO stock, worth $102,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
179,668
Previous 50,000
259.34%
Holding current value
$102,410
Previous $27,000
344.44%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SGMO
# of Institutions
124Shares Held
51.1MCall Options Held
1.12MPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA9.37MShares$5.34 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.08MShares$4.61 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.84MShares$3.9 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.68 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$1.33 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $89.2M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...